Further validation in CRC tissue samples and cell lines revealed a pronounced decrease in KCNMA1-AS2 expression in tumorous tissues across all the cancer specimens from 10 patients compared to non-tumorous samples. This evidence concerns the gene KCNMA1 and colorectal carcinoma.